The Hague, Nov 23 (AFP/APP):The European Medicines Agency said Tuesday it may decide “within weeks” whether to approve Merck’s anti-Covid pill, Lagevrio, which could offer patients an easy at-home treatment for the disease. “EMA will assess the benefits and risks of Lagevrio under a reduced […]
